Type 2 Diabetes With Obesity CagriSema REDEFINE 2 showed 13.7% weight loss with 73.5% of T2D patients achieving HbA1c of 6.5% or less, exceeding semaglutide's glycemic and weight results in T2D trials
For individuals managing type 2 diabetes, Semaglutide is often combined with other diabetes medications such as metformin, SGLT2 inhibitors, or insulin, depending on the patients needs and medical history
Its AI doctor synthesizes up-to-date, peer-reviewed medical knowledge and remembers prior visits to provide personalized advice
During this event, the leadership structure of counsel and committees was discussed along with other procedural aspects
Some patients may switch from tirzepatide to semaglutide because of tolerance, side effects, cost, availability or provider recommendation